Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cbd Alzheimer's:

Search results

Items: 1 to 20 of 260

1.

Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome.

Constantinides VC, Paraskevas GP, Efthymiopoulou E, Stefanis L, Kapaki E.

J Neurol Sci. 2019 Jan 29;398:142-147. doi: 10.1016/j.jns.2019.01.046. [Epub ahead of print]

PMID:
30711771
2.

FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, Nobili F, Ghetti B, Grafman J.

Neurology. 2019 Jan 30. pii: 10.1212/WNL.0000000000007038. doi: 10.1212/WNL.0000000000007038. [Epub ahead of print]

PMID:
30700592
3.

Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant.

Carlomagno Y, Chung DC, Yue M, Kurti A, Avendano NM, Castanedes-Casey M, Hinkle KM, Jansen-West K, Daughrity LM, Tong J, Phillips V, Rademakers R, DeTure M, Fryer JD, Dickson DW, Petrucelli L, Cook C.

Acta Neuropathol Commun. 2019 Jan 23;7(1):10. doi: 10.1186/s40478-019-0661-2.

4.

Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy.

Oliveira MCB, Ling H, Lees AJ, Holton JL, De Pablo-Fernandez E, Warner TT.

J Neurol Neurosurg Psychiatry. 2018 Dec 31. pii: jnnp-2018-319374. doi: 10.1136/jnnp-2018-319374. [Epub ahead of print]

PMID:
30598430
5.

Tau immunoreactivity in peripheral tissues of human aging and select tauopathies.

Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG.

Neurosci Lett. 2018 Dec 21;696:132-139. doi: 10.1016/j.neulet.2018.12.031. [Epub ahead of print]

PMID:
30579993
6.

Review: Fluid biomarkers for frontotemporal dementias.

Zetterberg H, van Swieten JC, Boxer AL, Rohrer JD.

Neuropathol Appl Neurobiol. 2019 Feb;45(1):81-87. doi: 10.1111/nan.12530. Epub 2018 Dec 3. Review.

PMID:
30422329
7.

Cannabis Therapeutics and the Future of Neurology.

Russo EB.

Front Integr Neurosci. 2018 Oct 18;12:51. doi: 10.3389/fnint.2018.00051. eCollection 2018.

8.

Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.

Kim EJ, Brown JA, Deng J, Hwang JL, Spina S, Miller ZA, DeMay MG, Valcour V, Karydas A, Ramos EM, Coppola G, Miller BL, Rosen HJ, Seeley WW, Grinberg LT.

J Neurol. 2018 Dec;265(12):2960-2971. doi: 10.1007/s00415-018-9086-2. Epub 2018 Oct 15.

PMID:
30324308
9.

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.

Rodríguez-Muñoz M, Onetti Y, Cortés-Montero E, Garzón J, Sánchez-Blázquez P.

Mol Brain. 2018 Sep 17;11(1):51. doi: 10.1186/s13041-018-0395-2.

10.

Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review.

Gibbons GS, Lee VMY, Trojanowski JQ.

JAMA Neurol. 2018 Sep 4. doi: 10.1001/jamaneurol.2018.2505. [Epub ahead of print]

PMID:
30193298
11.

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.

Jabbari E, Woodside J, Tan MMX, Shoai M, Pittman A, Ferrari R, Mok KY, Zhang D, Reynolds RH, de Silva R, Grimm MJ, Respondek G, Müller U, Al-Sarraj S, Gentleman SM, Lees AJ, Warner TT, Hardy J, Revesz T, Höglinger GU, Holton JL, Ryten M, Morris HR.

Ann Neurol. 2018 Oct;84(4):485-496. doi: 10.1002/ana.25308. Epub 2018 Sep 15.

12.

Early stage memory impairment, visual hallucinations, and myoclonus combined with temporal lobe atrophy predict Alzheimer's disease pathology in corticobasal syndrome.

Jung NY, Lee JH, Lee YM, Shin JH, Shin MJ, Lee MJ, Pak K, Hwang C, Ahn JW, Sung S, Choi KU, Huh GY, Kim EJ.

Neurocase. 2018 Jun;24(3):145-150. doi: 10.1080/13554794.2018.1494290. Epub 2018 Jul 10.

PMID:
29987978
13.

Tau in neurodegenerative disease.

Gao YL, Wang N, Sun FR, Cao XP, Zhang W, Yu JT.

Ann Transl Med. 2018 May;6(10):175. doi: 10.21037/atm.2018.04.23. Review.

14.

GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol.

Laun AS, Shrader SH, Brown KJ, Song ZH.

Acta Pharmacol Sin. 2019 Mar;40(3):300-308. doi: 10.1038/s41401-018-0031-9. Epub 2018 Jun 25. Review.

PMID:
29941868
15.

Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.

Noreen N, Muhammad F, Akhtar B, Azam F, Anwar MI.

Crit Rev Eukaryot Gene Expr. 2018;28(1):73-86. doi: 10.1615/CritRevEukaryotGeneExpr.2018021528.

PMID:
29773016
16.

Review of the neurological benefits of phytocannabinoids.

Maroon J, Bost J.

Surg Neurol Int. 2018 Apr 26;9:91. doi: 10.4103/sni.sni_45_18. eCollection 2018. Review.

17.

Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users.

Beale C, Broyd SJ, Chye Y, Suo C, Schira M, Galettis P, Martin JH, Yücel M, Solowij N.

Cannabis Cannabinoid Res. 2018 Apr 1;3(1):94-107. doi: 10.1089/can.2017.0047. eCollection 2018.

18.

Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.

Karch CM, Wen N, Fan CC, Yokoyama JS, Kouri N, Ross OA, Höglinger G, Müller U, Ferrari R, Hardy J, Schellenberg GD, Sleiman PM, Momeni P, Hess CP, Miller BL, Sharma M, Van Deerlin V, Smeland OB, Andreassen OA, Dale AM, Desikan RS; International Frontotemporal Dementia (FTD)–Genomics Consortium, International Collaboration for Frontotemporal Dementia, Progressive Supranuclear Palsy (PSP) Genetics Consortium, and International Parkinson’s Disease Genomics Consortium.

JAMA Neurol. 2018 Jul 1;75(7):860-875. doi: 10.1001/jamaneurol.2018.0372.

19.

Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease.

Hughes B, Herron CE.

Neurochem Res. 2018 Mar 24. doi: 10.1007/s11064-018-2513-z. [Epub ahead of print]

PMID:
29574668
20.

Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.

Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN, Irwin DJ, Trojanowski JQ, Lee VMY.

J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010.

PMID:
29415231

Supplemental Content

Loading ...
Support Center